- Tytuł:
- Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON–SEOM registry
- Autorzy:
- Źródło:
- Clinical and Translational Oncology. :1-13
Czasopismo naukowe